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Apical membrane antigen 1 (AMA1) is an essential compo-
nent of the moving junction complex used by Apicomplexan
parasites to invade host cells. We report the 2.0 A˚ resolution
x-ray crystal structure of the full ectodomain (domains I, II,
and III) of AMA1 from the pervasive protozoan parasite Tox-
oplasma gondii. The structure of T. gondii AMA1 (TgAMA1)
is the most complete of any AMA1 structure to date, with
more than 97.5% of the ectodomain unambiguously modeled.
Comparative sequence analysis reveals discrete segments of
divergence in TgAMA1 that map to areas of established func-
tional importance in AMA1 from Plasmodium vivax (PvAMA1)
and Plasmodium falciparum (PfAMA1). Inspection of the
TgAMA1 structure reveals a network of apical surface loops,
reorganized in both size and chemistry relative to PvAMA1/
PfAMA1, that appear to serve as structural filters restricting
access to a central hydrophobic groove. The terminal portion of
this groove is formed by an extended loop from DII that is 14
residues shorter in TgAMA1. A pair of tryptophan residues
(Trp353 and Trp354) anchor the DII loop in the hydrophobic
groove and frame a conserved tyrosine (Tyr230), forming a con-
tiguous surface that may be critical for moving junction assem-
bly. The minimalist DIII structure folds into a cystine knot that
probably stabilizes and orients the bulk of the ectodmain with-
out providing excess surface area to which invasion-inhibitory
antibodies can be generated. The detailed structural character-
ization of TgAMA1 provides valuable insight into the mecha-
nism of host cell invasion by T. gondii.
Toxoplasma gondii, the etiological agent of toxoplasmosis, is
a prevalent global pathogen capable of establishing acute and
chronic infections in nearly all warm blooded animals (1, 2).
Although largely asymptomatic in healthy individuals,T. gondii
infections can be lethal to a developing fetus and immunocom-
promised cancer and AIDS patients (3–6). Toxoplasmosis can
also result in severe ocular infections in both children and
adults, and encysted forms of the parasite have recently been
implicated in neuropsychiatric disorders, such as schizophre-
nia (7–9).
The success of T. gondii stems from its ability to persist in
the environment, utilize several modes of transmission (10),
and, importantly, to infect a broad range of host cells (1). A
dominant feature that endows T. gondii and, in fact, all Api-
complexan parasites, including Plasmodium, Babesia, Crypto-
sporidium, and Neospora, with the ability to efficiently invade
host cells is a multiprotein complex assembled at the moving
junction (MJ)4 (2, 11). The MJ is an electron-dense, ringlike
structure formed between the plasma membranes of the apical
tip of the motile parasite and the target host cell (12). During
invasion, T. gondii is rapidly engulfed within a parasitophorous
vacuole (PV) as the MJ traverses in a posterior direction along
the length of the parasite (13, 14). As it migrates, the MJ serves
as a molecular sieve, selectively filtering host proteins from the
PV (12, 15), thereby protecting the parasite from intracellular
degradation (16).
Despite the critical role of the MJ in host cell invasion, only
limited information exists describing the details of its assembly.
This is due, in part, to the absence of structural information for
the individual components. Importantly, however, studies with
T. gondii have identified rhoptry proteins RON2, -4, -5, and -8
as forming part of the MJ complex targeted to the cytoplasmic
face of the host cell membrane (17, 18). Despite an ambiguous
orientation of TgRON2 in the membrane, recent studies have
demonstrated a clear interaction between TgRON2 and the
micronemal protein AMA1 (apical membrane antigen 1) (17–
21), a core component of the MJ complex conserved across the
phylum. A ligand-receptor model predicts that the parasite is
able to provide its own ligand (TgAMA1) to the host cell-em-
bedded RON complex (TgRON2/4/5/8) to promote invasion
(18). This feature may explain the ability of Toxoplasma to
invade its remarkably extensive cell range from awide variety of
warm blooded animals.
AMA1 was originally identified as an invariant surface
antigen on Plasmodium knowlesi merozoites (22, 23), and
monovalent Fab fragments of monoclonal antibodies against
P. knowlesi AMA1 were sufficient to block in vitro invasion
of erythrocytes (24). Subsequent genetic and immunological
studies broadly established the importance of AMA1 as a core
component of the invasion machinery (21, 25–27). Complete
disruption of ama1 results in a lethal phenotype inPlasmodium
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(28) and T. gondii (26), whereas a conditional ama1 knock-out
in T. gondii resulted in tachyzoites severely compromised
for invasion (29). Immunological studies have shown that anti-
bodies to both native and recombinant AMA1 recognize a con-
formational epitope and are protective in animal models of
malarial infection (30–35). In addition, anti-AMA1 antibodies
extracted from donor sera collected from areas endemic for
malaria are both therapeutic and protective (36–38). The im-
portance of AMA1 in both host cell invasion and immune reg-
ulation has prompted extensive study (19, 29, 39–43), includ-
ing testing its potential as a malarial vaccine candidate.
Sequence analysis of AMA1 initially showed it to be a type
I integral membrane protein, composed of a small intracel-
lular C-terminal tail, a short trans-membrane region, and a
largeN-terminal ectodomain (26, 41). The three-domain archi-
tecture of the AMA1 ectodomain, originally proposed based on
the disulfide bonding pattern (44), was definitively shown in the
crystal structure of Plasmodium vivax AMA1 (PvAMA1). This
seminal study established that DI andDII adopted a PAN (plas-
minogen, apple, nematode) motif (45), a module defining a
diverse family of adhesins implicated in binding to protein or
carbohydrate receptors, while showing little structural homol-
ogy for DIII. Subsequent structural characterization of a trun-
cated ectodomain of P. falciparum (PfAMA1) incorporatingDI
andDII (39) allowed for delineation of surface loops disordered
in the original PvAMA1 structure (43). Of particular interest
was an extended non-polymorphic DII loop that, along with a
network of surface loops on DI, formed part of an apical hydro-
phobic groove. Mutation of a tyrosine (Tyr251-PfAMA1) to an
alanine located in the center of this groove was sufficient to
abrogate binding to RONs (19), highlighting the importance of
this structural feature in formation of the MJ complex (39). A
molecular interaction role was also proposed for DIII based on
the observations that, when expressed on Chinese hamster
ovary cells, DIII was sufficient to bind to the Kx membrane
protein on trypsin-treated erythrocytes (46). Although only the
original PvAMA1 structure included DIII in the context of DI
andDII (43), follow-up structural studies of PfAMA1DIII alone
and in complex with invasion inhibitory antibodies have pro-
vided further insight into potential functional roles for this
domain (19, 40, 42, 47–49).
AMA1 from P. falciparum and P. vivax are highly homolo-
gous with respect to sequence and structure. Comparative se-
quence analysis, however, reveals significant levels of diver-
gence with AMA1 from T. gondii and other Apicomplexan
parasites. Intriguingly, several of these divergent stretches map
to sites shown to participate in assembly of the MJ complex,
immune regulation, and host cell adhesion in Plasmodium
AMA1s. To accurately define the distinctive structural features
of TgAMA1, we have solved and refined the crystal structure of
the fully processed ectoplasmic region to 2.0 Å resolution. The
highly ordered structure provides a nearly complete view of the
inter- and intramolecular interactions of DI, DII, and DIII that
comprise the ectodomain. The structure of TgAMA1 provides
a critical step in defining its elusive rolewithin theMJ and,more
broadly, its contribution to the unique invasion characteristics
of T. gondii.
EXPERIMENTAL PROCEDURES
Bioinformatics—Boundaries for DI, DII, and DIII were de-
fined based on the paradigm established for PvAMA1 (43). Phylo-
genic analysiswasperformedusingMEGA4 (50, 51), andmultiple
sequences were aligned using Kalign (52, 53). Accession numbers
for aligned AMA1 sequences are as follows: T. gondii (ME49_
055260), Neospora caninum (BAF45372), P. falciparum (XP_
001348015.1), and Babesia bovis (AAS58045.1). The P. vivax
(XP_001615447) sequencewasmodified to reflect the sequence
crystallized by Pizarro et al. in 2005 (43).
Cloning, Expression, and Purification—A clone encoding the
fully processed ectoplasmic domain of TgAMA1was generated
in a modified pAcGP67b vector (Pharmingen) incorporating a
C-terminal hexahistidine tag and thrombin cleavage site. To
generate TgAMA1 encoding virus for insect cell protein pro-
duction, the TgAMA1 clone was transfected with linearized
baculovirus DNA into Sf9 cells and amplified to a high titer.
Hi-5 cells at 1.8  106 cells/ml were infected with amplified
virus for 72 h, after which time the supernatant was harvested,
concentrated, and applied to a HisTrapFF nickel affinity col-
umn. TgAMA1 was eluted with an increasing concentration of
imidazole with fractions analyzed by SDS-PAGE and pooled
based on purity. The hexahistidine tag was removed by throm-
bin cleavage, and TgAMA1 was further purified by size exclu-
sion chromatography (Superdex 16/60 200) inHEPES-buffered
saline (20 mM HEPES, pH 7.5, 150 mM NaCl). The final yield of
purified TgAMA1 was2 mg of purified protein/liter of insect
cell culture.
Crystallization and Data Collection—Crystals of TgAMA1
were initially identified in the Index Screen (Hampton Re-
search) and subsequently refined to a final condition of 20%
polyethylene glycol 3350, 100 mM HEPES, pH 7.5, and 50 mM
NaCl. Small crystals were observed after 2 days and grew to a
final size of 0.5 0.1 0.1 mm within 6 days. The final drops
consisted of 1.5l of protein (15mg/ml) with 1.5l of reservoir
solution and were equilibrated against 100 l of reservoir solu-
tion. Cryoprotection of the TgAMA1 crystal was carried out in
mother liquor supplemented with 5% glycerol and 5% ethylene
glycol for 20 s and flash-cooled at 100 K directly in the cryo-
stream.Diffraction datawere collected onbeamline 9-2 at SSRL
(Stanford Synchrotron Radiation Laboratory) at a wavelength
of 0.9794 Å. A total of 720 images were collected with a 1°
oscillation and 2-s exposure.
Data Processing, Structure Solution, and Refinement—Dif-
fraction data to 2.0 Å were processed using Imosflm (54) and
Scala (55) in the CCP4 suite of programs (56). Initial phases
were obtained by molecular replacement using MOLREP (57)
with the individual DI and DII domains of PfAMA1 (Protein
Data Bank code 2Q8A) prunedwith CHAINSAW (58) to better
reflect the TgAMA1 sequence. No molecular replacement
solution was obtained for DIII using a pruned or polyserine
model. Tracing of the DIII chain was ultimately achieved using
4-fold non-crystallographic symmetry averaging. Solvent mol-
ecules were selected using COOT (59), and refinement was car-
ried out using Refmac5 (57). The overall structure of TgAMA1
was refined to an Rcryst of 18.4% and an Rfree of 24.8%. Stereo-
chemical analysis performed with PROCHECK and SFCHECK
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in CCP4 (56) showed excellent stereochemistry, with more
than 95% of the residues in the favored conformations and
no residues modeled in disallowed orientations of the Ram-
achandran plot. Overall, 5% of the reflections were set aside
for calculation of Rfree. Data collection and refinement sta-
tistics are presented in Table 1.
RESULTS ANDDISCUSSION
Domain Divergence; Comparative Sequence Analysis of DI,
DII, and DIII—Domain boundaries of the fully processed
TgAMA1 ectodomain were defined based on the paradigm
established for PvAMA1 and PfAMA1 (Fig. 1). TgAMA1 DI
spans residues from Thr67 to Pro287 (residues numbered
from initiation methionine in the signal sequence), DII spans
from Asn288 to Asn415, and DIII spans from Phe416 to Ala487.
TgAMA1 is most closely related to AMA1 from N. caninum,
with 75% sequence identity distributed over the entire ectodo-
main. Increased evolutionary divergence is observed with
respect to AMA1s from P. falciparum, P. vivax, and B. babesi,
with DIII, in particular, displaying less than 10% sequence
identity.
Sequence analysis reveals a network of conserved cysteine
residues in DI and DII, suggesting a conserved structural core.
Several insertions and deletions in the primary sequence, how-
ever, map to functionally relevant sites in PvAMA1/PfAMA1
and may be responsible for the unique host cell invasion capa-
bilities of T. gondii. Six invariant cysteines in TgAMA1 DI are
supported by an overall moderate level of sequence identity
with denoted species (on average 35%) (Fig. 1, top). Several of
FIGURE 1.Phylogenic tree andmultiple sequence alignments of domains I, II, and III that comprise the ectodomain of AMA1 from T. gondii (TgAMA1),
N. caninum (NcAMA1), P. falciparum (PfAMA1), P. vivax (PvAMA1), and B. bovis (BbAMA1). Scale bars on the phylogenetic trees indicate evolutionary
distances. Cysteine residues are shown in red and numberedwith respect to disulfide bond partner based on the TgAMA1 crystal structure. Residues shown in
blue are either invariant or highly conserved in at least four of the five sequences. Domain boundaries were defined based on the paradigm established for
Plasmodium AMA1s (39).
TABLE 1
Data collection and refinement statistics
Values in parentheses are for the highest resolution shell.
Parameters Values
Data collection
Space group P1
a, b, c (Å) 66.15, 76.07, 88.25
, ,  (degrees) 72.19, 71.44, 72.90
Wavelength 0.9794
Resolution (Å) 52.24-2.00
Measured reflections 391,114 (56,271)
Unique reflections 98,629 (14,195)
Redundancy 4.0 (4.0)
Completeness (%) 96.4 (95.3)
I/(I) 13.7 (3.3)
Rmergea 0.074 (0.433)
Refinement statistics
Resolution range (Å) 43.90–2.00 (2.05–2.00)
Rcrystb 0.184 (0.228)
Rfreec 0.248 (0.309)
No. of atoms
Protein (chain A, B, D, E) 3225, 3202, 2932, 3149
Solvent 1177
Glycerol 6
B-values
Protein (chain A, B, D, E) (Å2) 25.08, 25.78, 26.28, 25.75
Solvent (Å2) 35.43
Glycerol (Å2) 25.89
Root mean square deviation from ideality
Bond lengths (Å) 0.02
Bond angles (degrees) 1.97
Ramachandran statistics
Most favored 95.3%
Allowed 4.7%
Disallowed 0.0%
aRmerge hkliIhkl,i Ihkl/hkliIhkl,i, where Ihkl is the average of symmetry-
related observations of a unique reflection.
bRcryst Fobs Fcalc/Fobs, where Fobs and Fcalc are the observed and the calcu-
lated structure factors, respectively.
c Rfree is R using 5% of reflections randomly chosen and omitted from refinement.
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the insertions are highly polar or proline-rich and map to
surface-exposed loops in PfAMA1 predicted to serve as
structural filters in governing access to a central groove (39).
A single eight-residue deletion at the N terminus of TgAMA1
DI may also carry functional implications as the additional
residues in PvAMA1 (43) form an extended strand that con-
nects DI and DIII. DII is approximately two-thirds the size of
DI and encodes four invariant cysteines but is less well con-
served, with an overall sequence identity of25% (Fig. 1,mid-
dle). Themost unique feature ofTgAMA1DII is a deletion of 14
residues that maps to the non-polymorphic DII loop of
PfAMA1 (39). Recent studies have shown that the PfAMA1DII
loop presents an epitope recognized by an invasion-inhibitory
monoclonal antibody and a T cell epitope implicated in the
human response to Plasmodium infection (39, 43, 44). The
greatest divergence among the AMA1 ectodomains, however,
is localized to DIII (Fig. 1, bottom),
which is nearly 50% shorter in
TgAMA1 relative to Plasmodium
AMA1s.Despite comprising only 71
residues, TgAMA1 DIII encodes six
cysteines, four of which align with
cysteines in PfAMA1/PvAMA1. By
contrast, B. bovis DIII encodes just
four cysteines, all of which align
with Plasmodium AMA1s consis-
tent with a more recent evolution-
ary divergence.
Protein Production, Crystalliza-
tion, and Structure Solution of the
TgAMA1 Ectodomain—Attempts to
produce soluble two-domain (DI and
DII) or three-domain (DI, DII, and
DIII) versions of TgAMA1 in Esche-
richia coli were unsuccessful. Ulti-
mately, we were able to recombi-
nantly produce a soluble form of the
fully processed TgAMA1 ectodo-
main (DI, DII, and DIII) using the
baculovirus strategy in insect cells.
Tangential flow concentration, nickel
affinity, and size exclusion chroma-
tographywereusedtopurifyTgAMA1
to homogeneity (Fig. 2A). Com-
parison of the TgAMA1 size ex-
clusion chromatography chromato-
gram against a series of globular
protein standards showed that
TgAMA1 eluted as amonomer con-
sistent with Plasmodium AMA1s
(39, 43).
TgAMA1 crystallized with four
molecules in the P1 unit cell.Molec-
ular replacement solutions were in-
dependently determined for TgAMA1
DI and DII using PfAMA1 DI and
DII as search models with the se-
quences pruned to reflect TgAMA1
and surface loops removed (39). No molecular replacement
solution was obtained for TgAMA1 DIII, and initial electron
density maps were inadequate to trace or even manually posi-
tion a DIII model. Phase improvement strategies incorporating
4-fold non-crystallographic symmetry averaging resulted in
maps intowhich all but three amino acids ofDIIIweremodeled.
Each polypeptide chain in the unit cell is largely equivalent with
respect to degree of modeled structure and organization as
shown by root mean square deviations relative to chain A of
0.61 Å over 361 C atoms (chain B), 0.53 Å over 353 C atoms
(chain D), and 0.44 Å over 386 C atoms (chain E). Chain A is
the most extensively modeled, yet a small section of loop in
chain A (Gln338–Asp352) is reorganized with respect to the
analogous regions in the three other NCS-related chains (sup-
plemental Fig. 1). This alternate conformation appears to be a
crystallization artifact arising from intermolecular packing.
FIGURE 2.Overall structure of the TgAMA1ectodomain.A, Superdex 200 gel filtration analysis showing that
TgAMA1 (red peak) elutes as a monomer of 50 kDa. The blue peaks represent protein standards: peak I,
conalbumin (75 kDa); peak II, ovalbumin (43 kDa); peak III, carbonic anhydrase (29 kDa). Inset, SDS-PAGE
analysis of the column fractions, with TgAMA1 migrating at 50 kDa (the expected molecular mass of the
TgAMA1 construct is 47,960 Da). B, secondary structure depiction of the TgAMA1 ectodomain displayed in the
predicted orientation with respect to the parasite cell surface. Purple, DI; green, DII; slate blue, DIII. C, topology
diagram of the TgAMA1 ectodomain (chain A) with cysteine residues depicted by numbered gold stars and
disulfide bonds as yellow dotted lines.
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Therefore, structural analysis of this region is based on the loop
conformation observed in chains B, D, and E.
Overall Structure—The assembled TgAMA1 ectodomain
extends 80 Å in height and, on average, 35 Å in width, as shown
in Fig. 2B with respect to its predicted orientation to the mem-
brane. Whereas the bulk of DI (Fig. 2B, purple) is positioned
atop DII (Fig. 2B, green), a series of short N-terminal helices
span the length of DII, resulting in the N terminus positioned
within 21Åof theC terminus ofDIII (Fig. 2B, slate blue). DI and
DII are intimately associated and form the bulk of the ectodo-
main, whereas the majority of the smaller DIII resides at the
posterior, membrane-proximal region (Fig. 2B).
The DI domain is composed of small helical bundles, short
twisted -sheets, and an extensive network of random coils.
Despite the low secondary structure content, DI is well ordered,
due, in part, to the trio of stabilizing disulfide bonds (Fig. 2C). The
core of DII is centrally located within the ectodomain with the
exception of a 33-residue loop (termed the DII loop) that packs
lengthwiseagainstDI, forminganextended interface (Fig.2B).The
base of the DII loop is stabilized by a disulfide bond with a second
disulfide bond stabilizing the DII core (Fig. 2C). A 25-residue
tether connects the core of DIII to DII, making it possible for
theDIII to be positioned at the posterior end of the ectodomain.
Of the remaining 46 residues that comprise the DIII core, six
are cysteines organized into three disulfide bonds that form a
structurally ultrastable cystine knot with disulfide bond 8
(Cys452–Cys479) threading through a ring formed by bond 6
(Cys435–Cys459) and bond 7 (Cys447–Cys471) (Fig. 2C).
Toprobe the levelof structural conservation, aDALI (60) search
was individually performed with TgAMA1 DI, DII, and DIII. As
expected, TgAMA1 DI shows a high level of structural homol-
ogy to PfAMA1/PvAMA1 (39, 43),
with Z scores ranging from 18 to 22.
Intriguingly, however, no structural
relationship was identified corre-
sponding to the protein-protein or
protein-carbohydrate interacting PAN
superfamily (45), as was originally
observed for PvAMA1 (43). It is
likely that the insertions and dele-
tions in TgAMA1 DI (Fig. 1) may
limit its categorization as part of the
PAN superfamily. Despite the lower
sequence and structural (Z scores
from 8 to 12.6) homology for DII
resulting from the 14-residue dele-
tion, a clear correlation (Z score of
7.5) is observed with PAN-contain-
ing proteins, such as hepatocyte
growth factor. This structural fea-
ture suggests that DII may partici-
pate in ligand recognition. No sta-
tistical structural similarity was
observed for DIII, consistent with
less than 10% sequence identity
observed.
Intimate Interfaces; Assembling the
TgAMA1 Ectodomain—The highly
ordered TgAMA1 structure provides an opportunity to thor-
oughly analyze the inter- and intramolecular interactions that
stabilize the structural framework of the ectodomain. Each
interdomain interface is formed from numerous non-covalent
forces and substantial shape complementarity, as shown by a
maximum complexation significance scores of 1.0 (61). To
visualize the extensive nature of the interdomain interactions,
an “open book” perspective is presented in Fig. 3 with residues
contributing to the interfaces displayed in orange.
In total, more than 7350 Å2 of surface area is buried upon
assembly of the TgAMA1 ectodomain. The largest interface
is formed between DI and DII, resulting in a buried surface
area of4849 Å2, with 2319 Å2 contributed from DI and 2530
Å2 from DII (Fig. 3A). The DI/DII interface is stabilized by 21
interdomain hydrogen bonds and three salt bridges (Asn288O-
Gln289N; Asp102O1-His357N1, and Arg259N-Glu330O1).
The role of polar interactions in defining the DI/DII interface is
highlighted by an electrostatic surface representation that
shows distinct complementary charged surfaces (Fig. 3A,mid-
dle). Additional polarity is provided by a small yet well ordered
network of buried solvent that may also serve to increase shape
complementarity. A major component of the DI/DII interface
is contributed by the DII loop that extends from Gly333 to
Arg369 and accounts for approximately half of the buried sur-
face area between the two domains. Although the majority of
the DII loop is structurally invariant across the fourmonomers,
intramolecular packing results in a contorted segment (Gln338–
Asp352) of the DII loop in chain A (Supplemental Fig. 1). As a
result, defining the contributions of the DII loop to ectodomain
stability is restricted to chains B, D, and E.
FIGURE3.Assemblyof theTgAMA1ectodomain.Orthogonal surface viewsof TgAMA1 (chain B) are oriented
with respect to the cell membrane; the DI domain is shown in purple, the DII domain in green, and the DIII
domain in slate blue (bottom center). An open book perspective provides a view of the interdomain interfaces
with buried residues shown in orange. Each interface shows a high degree of structural complementarity as
denoted by a complexation significance score of 1.0. A, opposing views of DI and DII are shown with one
domain represented as a surface and theother as a secondary structure tube. Thediameter of the tube is based
on B-factors, with larger diameters representingmore flexible regions. TheDII loop packs tightly against theDI
domain to form a structurally contiguous surface and contributes nearly half of the buried surface area. Elec-
trostatic representations of DI and DII highlight the charge complementarity that promotes assembly. B, the
DII/DIII interface is formed by a discontinuous epitope formed primarily by the core cystine knot of DIII. C, the
linker region that connects DIII to DII contributes to the buried surface area by packing against the lower
portion of DI.
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The core cystine knot of DIII displays a discontinuous
epitope and contributes 637 Å2 of buried surface area, with DII
contributing 663 Å2 for a total buried surface area of 1300 Å2
(Fig. 3B). Fourteen hydrogen bonds complement a bifurcated
salt bridge between the carboxylate side chain of Asp448 onDIII
and the -amino group of Lys301 and the -nitrogens of Arg303
on DII. The extended tether that connects DIII to the DI/DII
core also contributes to the total buried surface area of 1400 Å2
(740 Å2 from DI and 660 Å2 from DIII) (Fig. 3C). Despite the
increased surface area relative toDII/DIII, theDI/DIII interface
is stabilized by only six hydrogen bonds and one salt bridge
(Arg84NH1-Glu430O1). Instead, DI/DIII stability relies on
complementary hydrophobic surfaces where, for example, DI
Phe81 and DIII Phe416 provide the most individual buried sur-
face area of any interface residue. Overall, each domain is inti-
mately associated with the remaining two domains to form a
highly stable structure.
Structural Divergence in the Api-
cal Region of TgAMA1; Functional
Implications—Structural analysis re-
veals an extended groove at the
anterior, or membrane distal tip,
of the TgAMA1 ectodomain that
extends 30 Å in length and averages
10 Å in width (Fig. 4A, inset, hori-
zontal black bar).
Surface loops (identified by yel-
low numbers in Fig. 4A, inset) span
the length of the groove and proba-
bly serve as a selectivity filter in
mediating access to the base of the
groove as proposed for PfAMA1
(39). To assess potential func-
tional implications of these loops,
we present structural overlays with
the analogous loops in PfAMA1 (40)
(Fig. 4A).
Loops 1 and 2 are centrally posi-
tioned on opposite sides of the
groove, constricting the central seg-
ment to 6 Å. Despite loop 1 being
only three residues (Pro164, Ser165,
andGly166) longer than the analogous
loop in PfAMA1, it is significantly
reorganized (Fig. 4A, 1) in structure
yet well ordered as shown by low
B-factors. In PfAMA1, this loop
directly coordinates a series of inva-
sion-inhibitory antibodies (40, 47),
thereby playing a critical role in
pathogenesis. The altered structure
of loop 1 in TgAMA1 may, there-
fore, promote diversity in ligand
recognition. A high degree of flexi-
bility is observed in the apical region
of loop 2, resulting in three unmod-
eled residues, yet the overall size
is similar between TgAMA1 and
PfAMA1 (Fig. 4A, 2). A second set of loops, denoted as loops 3
and 4 in TgAMA1, extend the groove to incorporate the tip of
the DII loop. The size of the  hairpin structure in loop 3 is
largely conserved (Fig. 4A, 3), although the loop is shifted 1.5 Å
toward the central groove in TgAMA1. This displacement is
probably due to the reorganized DII loop that is much smaller
in TgAMA1. Amore striking structural reorganization coupled
to the smaller DII loop is observed in loop 4 (Fig. 4A, 4), where
the base of the loop provides a hydrophobic backstop with sub-
stantial shape complementarity to accommodate the DII loop.
The tip of loop 4, however, is highly polar with Glu145, Lys146,
Lys149, and Gln150 directed away from the base of the groove,
where it may serve as the initial structural filter in defining
appropriate ligands. Loops 5 and 6 are positioned at the periph-
ery of the central groove and form a contiguous surface that
appears to be critical in promoting correct orientation of the
DII loop in the central groove (Fig. 4A, 5 and 6).
FIGURE 4. Structural and functional implications of the TgAMA1 apical surface. A, surface representations
showing the TgAMA1 ectodomain (chain B) with top and end-on views of the membrane distal, apical region
with DI and DII colored purple and green, respectively. The black line in the top view represents the surface
groove, and the black triangle in the end-on view denotes depth, where thewide part of the triangle is directed
toward the viewer. The network of surface loops that define the central groove in TgAMA1 are numbered 1–6
and displayed in yellow on the surface of TgAMA1. Zoomed in views of each loop comparedwith the analogous
loops in PfAMA1 (Protein Data Bank code 2Q8A) (40) are shown in the inset boxes labeledwith the appropriate
loop number. See “Results and Discussion” for a detailed description of each loop. B, the DII loop (green) is
displayed in secondary structure format packed against the surface of DI (purple). The analogous DII loop
(orange) from PfAMA1 is shown for comparison. A pair of tryptophan residues (Trp353 and Trp354) on the
TgAMA1DII loop interdigitates into pockets onDI bifurcated by the conserved Tyr230. The ordered structure of
Trp353, Trp354, Tyr230, and associated solvent network is shown as a Sigma A-weighted electron density map
contoured at 1.3. C, the hydrophobic base of the central grooves in TgAMA1 and PfAMA1 are shown in green
with the remainder of the surface shown in gray. Black numbers identify the individual surface loops described
above. The red secondary structure represents a portion of the invasion inhibitory antibody 141-1 co-crystal-
lized with PfAMA1 (Protein Data Bank code 2Z8V) (47). Note the structural conservation of the central tyrosine
(Tyr230 in TgAMA1 and Tyr251 in PfAMA1) on DI despite the significant reorganization of the DII loop.
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The TgAMA1 DII loop (Fig. 4B) is composed of random
coil, yet it is reasonably well ordered due to the tight packing
against DI. A pair of tryptophan residues (Trp353 and Trp354)
forms the tip of the DII loop interdigitating into discrete
hydrophobic pockets on DI (Fig. 4B). The first pocket is
formed on one side by Leu155, Tyr148, Val142, and Pro143 from
the base of loop 4 and on the opposite side by Tyr230. The
second pocket, which accommodates Trp354 from the DII
loop, also makes use of Tyr230 and is completed by Tyr215,
Val105, Ala203, Tyr213, and Tyr110 derived from loops 2 and 3.
Note that despite the reorganization of Gln338 to Asp352
from the DII loop in chain A, the region encompassing
Trp353 and Trp354 is well anchored and structurally con-
served across each of the four monomers (supplemen-
tal Fig. 1). Although the presentation of the tryptophan pair
in TgAMA1 is not conserved in PfAMA1, the central tyro-
sine (Tyr230 in TgAMA1; Tyr251 in PfAMA1) is invariant,
with a root mean square deviation of less than 0.2 Å (Fig. 4B,
middle). The conserved location of this tyrosine suggests a
key role in defining the function of the central groove, and,
indeed, mutation of Tyr251 in PfAMA1 to alanine was suffi-
cient to abrogate formation of theMJ complex (19). Based on
these observations and the recent evidence of a direct inter-
action between TgAMA1 and RON2 in the absence of
RON4, -5, and -8 (18), we predict that this central tyrosine
may serve as a hot spot residue in mediating AMA1-RON2
complex formation.
In addition to the central tyrosine, the residues that form the
base of the central groove are primarily hydrophobic, leading to
the initial description as a hydrophobic trough in the PvAMA1
(43) and PfAMA1 (39) crystal structures. In TgAMA1, 15 resi-
dues (Ile185, Leu179, Phe174, Phe197, Ile171, Phe163, Ile161,Met203,
Tyr230, Val142, Trp354, Val231, Trp353, Trp253, and Leu155) form
the hydrophobic trough. Of these, 10 are spatially conserved
with PfAMA1, where the original nine-residue trough (39) was
recently expanded to 12 residues (40). The additional hydro-
phobic residues in TgAMA1 form a second layer of hydropho-
bicity near the constricted region between loops 1 and 2 and
compensate for the polar substitution of Thr201 in TgAMA1
loop 2 for the structurally analogous Met224 in PfAMA1,
thereby maintaining a contiguous hydrophobic surface. An
additional noteworthy feature is a small yet well defined solvent
network incorporating the hydroxyl group of Tyr230 (Fig. 4B,
bottom). Overall, the hydrophobic trough in TgAMA1 is
shorter and wider relative to the analogous region in PfAMA1
(Fig. 4C, left and right). This, in conjunction with the reorga-
nized network of surface loops, may define the divergent rep-
ertoire of host cells infected by Toxoplasma and Plasmodium.
Global Structural Rearrangement in TgAMA1 DIII—The
structural reorganization of the TgAMA1 apical region (DI/
DII) is likely to have a profound impact on assembly of the MJ
complex, yet it is DIII that displays the most divergence
between TgAMA1 and PvAMA1/PfAMA1. This observation
is especially interesting because DIII has been directly impli-
cated in mediating erythrocyte adhesion with PfAMA1 (46).
Thus, the reorganization of TgAMA1 DIII may also contrib-
ute to the broad infectivity of T. gondii.
A comparative structural analysis revealed a rationale for
why TgAMA1 DIII was substantially smaller than PvAMA1/
PfAMA1 DIII (Fig. 5). As described above, the N terminus of
PvAMA1 DI is eight residues longer than in TgAMA1 with
the additional residues adopting a single  strand that
extends away from the DI core toward DIII. PvAMA1 DIII
forms a saddle-like structure with a central groove to accom-
modate and stabilize this N-terminal extension. The shorter
N-terminal region of TgAMA1 DI does not extend to DIII
and therefore obviates the need for additional stabilizing
features contributed by DIII. Interestingly, the minimalist
structure of TgAMA1 DIII is sufficiently large to adopt the
structurally ultrastable cystine knot that may serve as a foun-
dation to properly orient the DI/DII core with respect to
the parasite cell membrane. In addition to a base structural
role, the smaller TgAMA1 DIII provides little excess surface
area to which growth inhibitory antibodies might be gener-
ated as recently suggested for PfAMA1 DIII (48). In this
study, engineered peptodomimetics of PfAMA1 DIII were
used to identify two immunodominant epitopes comprising
the linear sequences KRIKLN and DEGNKKII capable of
generating a protective antibody response (48). With the
exception of the two terminal isoleucine residues, the resi-
dues that comprise these epitopes are located in the diver-
gent region of PfAMA1 DIII not represented in the smaller
TgAMA1 DIII (Fig. 1).
FIGURE 5. Structural divergence in DIII. The DI and DII domains of TgAMA1
(chain A) and PvAMA1 (Protein Data Bank code 1W81) (43) are displayed as
gray surfaces in the same orientation. The TgAMA1 and PvAMA1DIII domains
are shown in slate blue andmagenta secondary structures, respectively. Cys-
teine residues that define the cystine knot configuration are shown as yellow
side chains.
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CONCLUSIONS
T. gondii is one of the most successful parasites, yet a
detailed molecular mechanism describing assembly and
function of the MJ complex remains elusive. The highly
ordered crystal structure of TgAMA1 presented herein
reveals an intriguing level of divergence from its Plasmo-
dium counterparts. While maintaining a conserved struc-
tural core in DI and DII, reorganized structural elements in
TgAMA1 map to areas of established functional importance
in PfAMA1, including a network of surface loops that frame
a central hydrophobic groove. Because AMA1 is vital for
parasitic invasion and has been previously shown to interact
with a variety of other proteins during MJ formation, the
implications of novel features leading to altered ligand bind-
ing sites are profoundly significant. More specifically, we
predict that the hydrophobic groove (and in particular
Tyr230) plays a key role in engaging RON2 during assembly of
the MJ complex. Our structure of the complete TgAMA1
ectodomain will help catalyze a better understanding of the
role AMA1 plays in host cell invasion by T. gondii and,
indeed, all Apicomplexan parasites. The structural details
provided here will also be useful to refine AMA1 vaccine
development efforts for both Plasmodium and Toxoplasma.
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